Friday, April 17, 2026
wellness India Expo
Home Tags Vaccine

Tag: Vaccine

India’s first mRNA based Omicron-specific booster vaccine from Gennova gets DCGI...

The Omicron specific mRNA vaccine will be available under the name - GEMCOVAC®-OM. The intradermal vaccine is stable at 2-8 °C and is administered using a needle-free device

Co-WIN portal safe, adequate security measures in place: Health Ministry

The Health Ministry has clarified that media reports that suggested data breach are without any basis and mischievous in nature

Building Dengue-Free Communities: Initiatives taken by govts to bring vaccines on...

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights into key factors driving demand for dengue vaccines

Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on...

The potential for lucrative settlements in the multi-billion-dollar COVID-19 vaccine market adds further significance to these legal battles

Cadila Pharma’s rabies vaccine ‘ThRabis’ wins top honour at Golden Globe...

Launched in April last year, ThRabis is the world’s first three-dose recombinant nanoparticle-based rabies G protein vaccine

GSK launches Shingrix in India- A vaccine for the prevention of...

New data show Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and over

India’s rise to global vaccine triumph: A journey of excellence &...

India's rich history with vaccines is a testament to the country's commitment to global health

India’s Evergreen Vaccine Story

India's biotechnology industry is positioned to become a significant engine of the Indian economy, writes Suchitra Ella, Managing Director, Bharat Biotech International Limited  

Indian Immunologicals receives regulatory approval for Measles-Rubella vaccine  

This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years

Indian Immunologicals continues its venture in fish vaccine development, signs agreement...

The company partners with Central Institute of Freshwater Aquaculture (CIFA), an Indian Council of Agricultural Research Institute for the commercial development of vaccine against Hemorrhagic Septicemia in freshwater fishes